Last reviewed: June 23, 2026
Last updated: June 23, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
A standard semaglutide pen delivers medication over a 4-week treatment cycle, with most patients progressing through a dose escalation schedule starting at 0.25 mg and moving toward maintenance doses of 1 to 2.4 mg weekly. PlexusDx compounded semaglutide injections follow this evidence-based trajectory, allowing your healthcare provider to adjust your therapy based on your individual response and genetic profile without increasing your monthly cost.
Understanding Semaglutide Pen Duration and Dosing Schedule
Semaglutide is administered as a once-weekly subcutaneous injection that follows a stepwise dose escalation over four weeks before reaching a target maintenance dose. Each pen contains multiple pre-measured doses, and the total duration depends on which dose strength you're using and where you are in your treatment timeline. Patients typically begin at 0.25 mg in week one, increase to 0.5 mg in week two, move to 0.75 mg in week three, and advance to 1 mg in week four. This gradual approach helps your body adapt to the medication and reduces gastrointestinal side effects.
The actual lifespan of a single pen varies based on whether you're using a 1 mg, 1.7 mg, or 2.4 mg formulation. A 1 mg pen contains four pre-filled doses of 0.25 mg each, making it suitable for the first month of treatment during dose escalation. Once you reach maintenance dosing—typically 1 to 2.4 mg weekly—you'll need higher-strength pens or multiple pens per month depending on your prescribed maintenance dose. PlexusDx compounded semaglutide injections are supplied in vials that your healthcare team fills according to your personalized dosing schedule, eliminating guesswork about pen duration.
How Compounded Semaglutide Differs From Branded Pens
Branded semaglutide products come in pre-filled pens with fixed dose increments, whereas PlexusDx compounded semaglutide from licensed 503A compounding pharmacies is prepared in sterile vials and administered with standard insulin syringes. This approach offers flexibility: your provider can prescribe your exact starting dose and increase frequency tailored to your metabolic response, rather than following a rigid four-pen escalation ladder. Compounded formulations also eliminate the need to purchase multiple branded pens at different strengths, reducing waste and simplifying your treatment routine.
A key advantage of compounded semaglutide is transparent, predictable monthly pricing. PlexusDx charges a flat rate of $149 per month for compounded semaglutide injection regardless of which dose you're taking—your dose may need to go up, but your price won't. This contrasts with branded pens, where higher-dose formulations often cost significantly more. Additionally, compounded semaglutide is prepared by licensed pharmacies under strict quality standards and is available to residents of all 50 states without insurance requirements.
Typical Treatment Timeline and Refill Frequency
Most patients enter week one of treatment with a 0.25 mg dose, progress through weeks two and three, and reach their week-four maintenance dose around day 28. At that point, your body has adjusted to the medication, and your healthcare provider can assess tolerability and efficacy before deciding whether to hold at 1 mg, escalate to 1.7 or 2.4 mg, or adjust the injection frequency. The entire dose escalation phase typically spans four weeks, meaning your first vial or pen lasts approximately one month before you transition to maintenance dosing.
Beyond the first month, refill timing depends on your maintenance dose. Patients taking 1 mg weekly need a vial every four weeks, while those at 2.4 mg weekly may require refills every two to three weeks depending on vial concentration. PlexusDx coordinates refills with your provider, ensuring your supply aligns with your prescribed dose and injection schedule. Your monthly flat rate covers whatever dose volume you're taking, so increasing your dose doesn't trigger a price increase—keeping your treatment affordable as you find your therapeutic sweet spot.
Personalization: How Genetic Testing Optimizes Your Semaglutide Timeline
Response to semaglutide varies significantly based on genetic factors affecting appetite regulation, satiety signaling, and metabolic rate. PlexusDx Precision Peptide Genetic Test examines 49 peptides across 14 metabolic pathways, including key variants like GLP1R rs6923761 and FTO rs9939609 that influence how your body responds to GLP-1 receptor agonists. Patients with certain GLP1R variants may show stronger satiety signals at lower doses, while those with FTO variants affecting energy balance might benefit from steady escalation toward higher maintenance doses.
Understanding your genetic peptide profile helps your PlexusDx provider predict your optimal maintenance dose and timeline more precisely. Rather than following a one-size-fits-all escalation schedule, your provider uses this genetic insight to adjust your dose increments and assess readiness to move between stages. The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, making personalization affordable and accessible. This approach reduces trial-and-error adjustments and gets you to your effective maintenance dose faster, maximizing your treatment efficiency within the same flat monthly cost.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many weeks does one semaglutide pen actually last?
A standard 1 mg semaglutide pen contains four pre-filled doses (0.25 mg each) and lasts approximately four weeks during the initial dose escalation phase. After reaching maintenance dosing, duration depends on your prescribed dose strength—a 2.4 mg weekly dose may require a new vial every two to three weeks. PlexusDx compounded semaglutide is supplied in vials tailored to your exact schedule, eliminating the need to juggle multiple pen strengths.
Why does compounded semaglutide cost less than branded pens if the active ingredient is the same?
Compounded semaglutide from licensed 503A pharmacies avoids branding, packaging, and marketing costs associated with branded formulations. PlexusDx passes these savings directly to you at a flat $149 monthly rate regardless of dose, whereas branded pens charge premium prices for higher-strength formulations. Both are medically equivalent when compounded by licensed facilities, but compounded versions offer accessibility and affordability.
Does PlexusDx require insurance or a membership fee?
PlexusDx compounded semaglutide is available to all 50 states with no insurance requirement and no membership fee. Your monthly cost is $149 flat, and the medication is HSA/FSA eligible, making it accessible whether or not you have traditional insurance coverage. You pay one transparent monthly rate regardless of your dose level.
What happens if semaglutide isn't working well for me after four weeks?
If you experience side effects or insufficient appetite suppression after reaching your week-four dose, your PlexusDx provider can adjust your timing, inject frequency, or consider alternative compounds like tirzepatide without penalizing your monthly cost. Your dose may be titrated down, held at the same level, or escalated depending on your tolerance and goals—all within the same $149 monthly rate for semaglutide injection.
How can the Precision Peptide Genetic Test help me know which dose I'll need?
PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes that predict your metabolic response to semaglutide. Patients with strong GLP1R signaling may achieve satiety at 1 mg, while those with certain FTO variants might benefit from advancing toward 2.4 mg for sustained weight loss. This $99 test, added after your first month, gives your provider a data-driven roadmap to your optimal maintenance dose, reducing guesswork and accelerating results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Get Oral Ozempic: A Comprehensive Guide
Unpacking the Truth: Does Ozempic Really “Eat Fat” on Your Weight Loss Journey?